Teva Pharmaceutical Industries Newswire

Teva Pharmaceutical Industries Newswire

Comprehensive Real-Time News Feed for Teva Pharmaceutical Industries.

Results 1 - 20 of 1,603 in Teva Pharmaceutical Industries

  1. Cipla, Aurobindo Pharma acquire products divested by Teva in USRead the original story w/Photo

    17 hrs ago | PR Log

    PUNE, India - July 30, 2016 - PRLog -- Hyderabad: Cipla Ltd, India's fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc's generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details.

    Comment?

  2. Teva Pharmaceutical Industries' (TEVA) "Overweight" ...Read the original story w/Photo

    Friday | Daily Political

    They currently have a $75.00 target price on the stock. Teva Pharmaceutical Industries traded down 2.35% during midday trading on Tuesday, reaching $53.50.

    Comment?

  3. Mylan's Weakness Shouldn't Last, So Buy NowRead the original story w/Photo

    Friday | TheStreet.com

    Mylan shares are about down 40% from the highs reached in spring 2015 after Teva Pharmaceutical tried to buy the company for $82 a share -- a bid that management deemed inadequate and essentially didn't even consider. Beyond management taking actions that seem to ignore shareholder interest by not entertaining buyout offers and trying to pursue their own acquisitions, the stock's sell-off was accelerated by the generic, specialty pharmaceutical and drug group falling out of favor with investors.

    Comment?

  4. Chinese Bankers With Global Ambitions Eye Middle East Mega BondsRead the original story

    Friday | The Washington Post

    ... In July alone, the Chinese bank helped a Bulgarian energy company, a Kazakh oil producer and Teva Pharmaceutical Industries Ltd. of Israel sell bonds. It's all part of an expansion strategy to give borrowers access to Bank of China's network in a ...

    Comment?

  5. Teva Wins U.S. Nod for Actavis After Divestiture of 79 DrugsRead the original story

    Thursday | The Washington Post

    The U.S. Federal Trade Commission approved Teva Pharmaceutical Industries Ltd.'s $40.5 billion purchase of Allergan Plc's generic drug-making unit after the companies agreed to the biggest divestiture ever in a pharmaceutical merger to preserve competition. The companies agreed to sell 79 existing and future drugs including anesthetics, antibiotics, weight-loss drugs and oral contraceptives to 11 rival firms to win approval, according to an FTC statement Wednesday.

    Comment?

  6. Mizuho Reaffirms Buy Rating for Teva Pharmaceutical Industries LtdRead the original story w/Photo

    Thursday Jul 28 | Daily Political

    Several other research analysts have also commented on TEVA. Piper Jaffray Cos. reissued a hold rating and set a $58.00 price objective on shares of Teva Pharmaceutical Industries in a report on Tuesday, May 31st.

    Comment?

  7. Teva To Report Second Quarter 2016 Financial Results On August 4, 2016Read the original story

    Wednesday Jul 27 | BioSpace

    Teva Pharmaceutical Industries Ltd. announced today that it will release its second quarter 2016 financial results on Thursday, August 4, 2016 at 7:00 a.m. ET. Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its second quarter 2016 results and overall business environment.

    Comment?

  8. Press Digest- New York Times business news - July 28Read the original story

    Thursday Jul 28 | Reuters

    ... strong mobile ad sales, as well as a steady ascent in its number of users. nyti.ms/2asdr7T - Teva Pharmaceutical Industries won U.S. antitrust approval to buy Allergan's generics business after agreeing to sell 79 generic drugs to rival firms. ...

    Comment?

  9. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story w/Photo

    Wednesday Jul 27 | Business Wire

    ... intelligent site management, cell site optimization, and outside plant solution... )--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that it will release its second quarter 2016 financial results on Thursday, August 4, 2016 at 7:00 ...

    Comment?

  10. 's M&A Chatter for Wednesday July 27, 2016Read the original story

    Wednesday Jul 27 | Benzinga

    ... per share for the entire issued and to be issued share capital of SABMiller. The Approval : Teva Pharmaceutical Industries Ltd., (NYSE: TEVA ) and Allergan plc (NYSE: AGN ) announced Wednesday, that the U.S. FTC has accepted the proposed consent ...

    Comment?

  11. FTC Requires Teva to Divest Over 75 Generic Drugs to Rival Firms to...Read the original story

    Wednesday Jul 27 | PressReleasePoint

    Teva Pharmaceutical Industries Ltd. has agreed to sell the rights and assets related to 79 pharmaceutical products to settle FTC charges that its proposed $40.5 billion acquisition of Allergan plc's generic pharmaceutical business would be anticompetitive . The remedy requires Teva to divest the drug portfolio to eleven rival firms, and marks the largest drug divestiture order in an FTC pharmaceutical merger case.

    Comment?

  12. US regulators just gave the green light for Teva's...Read the original story w/Photo

    Wednesday Jul 27 | Silicon Alley Insider

    A building belonging to Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to purchase Allergan Plc's generics business, after agreeing to divest 79 generic drugs to rival firms, the Federal Trade Commission said on Wednesday. The $40.5 billion deal, which was announced in July 2015, solidifies Teva's position as the world's No.

    Comment?

  13. Venezuela Roils Corporate Profits in US, ElsewhereRead the original story w/Photo

    Wednesday Jul 27 | Voice of America

    ... have signaled future writedowns if the country's economy remains in severe distress. Israel's Teva Pharmaceutical Industries Ltd., for example, in May said it still has about $350 million worth of assets exposed to Venezuela's currency. The company ...

    Comment?

  14. Teva, Allergan Get FTC Approval for Generics PurchaseRead the original story

    Wednesday Jul 27 | WRKO-AM Brighton

    Teva Pharmaceutical Industries Ltd. on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of Allergan PLC's generics business, conditioned upon Teva's divestiture of 75 drugs to rivals.

    Comment?

  15. Teva expect to close $40.5B Allergan generic deal next weekRead the original story w/Photo

    Wednesday Jul 27 | The New Zealand Herald

    ... if the sale went through. Shares of Allergan PLC rose $11.29, or 4.5 percent, to $260.24 and Teva Pharmaceutical Industries Ltd. stock added 85 cents, or 1.6 percent, to $55.16.

    Comment?

  16. U.S. FTC blesses Teva purchase of Actavis GenericsRead the original story w/Photo

    Wednesday Jul 27 | Seeking Alpha

    The U.S. Federal Trade Commission accepts the proposed consent order related to Teva Pharmaceutical Industries' acquisition of Actavis Generics . The transaction, now valued at ~$35B, should close next week.

    Comment?

  17. Venezuela roils corporate profits around the globeRead the original story w/Photo

    Wednesday Jul 27 | Channelnewsasia.com

    ... have signaled future writedowns if the country's economy remains in severe distress. Israel's Teva Pharmaceutical Industries Ltd, for example, said in May it still has about US$350 million worth of assets exposed to Venezuela's currency. The company ...

    Comment?

  18. Teva Wins U.S. Nod for Actavis After Divestiture of 79 Drugs an hour agoRead the original story w/Photo

    Wednesday Jul 27 | Bloomberg

    The U.S. Federal Trade Commission approved Teva Pharmaceutical Industries Ltd.'s $40.5 billion purchase of Allergan Plc's generic drug-making unit after the companies agreed to the largest divestiture ever in a pharmaceutical merger case to preserve competition. The companies agreed to sell 79 existing and future drugs including anesthetics, antibiotics, weight-loss drugs and oral contraceptives to eleven rival firms to win approval, according to an FTC statement Wednesday.

    Comment?

  19. Teva purchase of Allergan generics business approved with conditionsRead the original story

    Wednesday Jul 27 | Reuters

    Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to purchase Allergan Plc's generics business, after agreeing to divest more than 75 generic drugs to rival firms, the Federal Trade Commission said on Wednesday. The $40.5 billion deal, which was announced in July 2015, solidifies Teva's position as the world's No.

    Comment?

  20. Teva purchase of Allergan generics business gets OK with conditionsRead the original story w/Photo

    Wednesday Jul 27 | Channelnewsasia.com

    Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to purchase Allergan Plc's generics business, after agreeing to divest more than 75 generic drugs to rival firms, the Federal Trade Commission said on Wednesday. A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem March 23, 2010.

    Comment?